Skip to search formSkip to main contentSkip to account menu

flunixin meglumine

Known as: 2-((2-methyl-3-(trifluoromethyl)- phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded, meglumine flunixin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVE To examine the effects of flunixin meglumine (FM) on recovery of colonic mucosa from experimentally induced ischemia in… 
2007
2007
We examined the pharmacokinetic interactions of enrofloxacin and flunixin in male ICR mice that were subcutaneously (SC… 
1996
1996
OBJECTIVE To determine pharmacokinetic variables that describe the disposition of flunixin after i.v. administration of flunixin… 
1995
1995
Flunixin meglumine (FM), an inhibitor of the cyclo-oxygenase pathway of the prostaglandin synthesis, was used to evaluate the… 
1990
1990
Flunixin meglumine (FM) was injected in 2 oophorectomized cows to follow changes in basal levels of the main circulating… 
1990
1990
Uremia unexpectedly developed in five dogs 24 hours after undergoing thoracotomy in a student laboratory. In all dogs general… 
1988
1988
In a study to evaluate the effect of flunixin meglumine on secretory diarrhea, 11 calves were assigned to 3 groups: group 1 (n… 
1977
1977
The N-methyl-d-glucamine salt of flunixin (flunixin meglumine) is a potent non-narcotic analgesic agent after parenteral…